135 related articles for article (PubMed ID: 36053792)
1. Letter to the editor: Could COVID-19 vaccination reduce postinfection mortality in most patients with cirrhosis?
Lo GH
Hepatology; 2023 Feb; 77(2):E32. PubMed ID: 36053792
[No Abstract] [Full Text] [Related]
2. COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status.
Cao Z; Zhang C; Zhao S; Sheng Z; Xiang X; Li R; Qian Z; Wang Y; Chen B; Li Z; Liu Y; An B; Zhou H; Cai W; Wang H; Gui H; Xin H; Xie Q
Infect Dis Poverty; 2022 May; 11(1):56. PubMed ID: 35578350
[TBL] [Abstract][Full Text] [Related]
3. Letter to the editor: Postvaccination COVID-19-related mortality in patients with cirrhosis: Who is the culprit?
Duan Z
Hepatology; 2023 Jan; 77(1):E13. PubMed ID: 36065521
[No Abstract] [Full Text] [Related]
4. Letter to the Editor Regarding: What Triggers Takotsubo After a SARS-CoV-2 Vaccination? Heart Lung Circ. 2021;30(12):e119-20.
Finsterer J; Stollberger C
Heart Lung Circ; 2022 May; 31(5):e76-e77. PubMed ID: 35063380
[No Abstract] [Full Text] [Related]
5. Reponse to Letter to The Editor: Regarding: Evaluation of vaccination status of health care workers for recommended vaccines and their acceptance of SARS-CoV-2 vaccines.
Oygar PD; Kara A
Hum Vaccin Immunother; 2022 Nov; 18(6):2106748. PubMed ID: 35939650
[No Abstract] [Full Text] [Related]
6. Coronavirus disease 2019 (COVID-19) vaccination in patients with cirrhosis: Does it work?
Calleri A; Saracco M; Romagnoli R; Martini S
Hepatol Commun; 2022 Jun; 6(6):1502-1503. PubMed ID: 35429145
[TBL] [Abstract][Full Text] [Related]
7. Severe rhabdomyolysis and SARS-CoV-2 vaccination: a reply to the letter by Dr. Josef Finsterer.: Reply to Letter to the Editor regarding our report to Dr. Finsterer.
Kamura Y; Matsue K
Int J Infect Dis; 2022 Sep; 122():1005. PubMed ID: 35760377
[No Abstract] [Full Text] [Related]
8. COVID-19 Vaccination in Patients with Chronic Liver Disease.
Schinas G; Polyzou E; Mitropetrou F; Pazionis A; Gogos C; Triantos C; Akinosoglou K
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560782
[TBL] [Abstract][Full Text] [Related]
9. Letter to the editor: COVID-19 vaccinations in pregnancy.
Mungmunpuntipantip R; Wiwanitkit V
Int J Gynaecol Obstet; 2023 Feb; 160(2):719. PubMed ID: 36537309
[No Abstract] [Full Text] [Related]
10. Letter to the Editor: Rule Out Alternative Mechanisms Before Attributing Elevated Hemidiaphragm to Parsonage Turner Syndrome and SARS-CoV-2 Vaccination.
Finsterer J; Scorza FA
J Korean Med Sci; 2022 Nov; 37(43):e322. PubMed ID: 36345259
[No Abstract] [Full Text] [Related]
11. Safety and Immunogenicity of SARS-CoV-2 Vaccines in Patients With Chronic Liver Diseases (CHESS-NMCID 2101): A Multicenter Study.
Ai J; Wang J; Liu D; Xiang H; Guo Y; Lv J; Zhang Q; Li J; Zhang X; Li Q; Liang J; Guo X; Feng Y; Liu L; Zhang X; Qin W; Wang X; Rao W; Zhang Q; Tian Q; Zhang Y; Xie F; Jiang S; Yan Y; Qiu Y; Wu H; Hou Z; Zhang N; Zhang A; Ji J; Yang J; Huang J; Zhao Z; Gu Y; Bian L; Zhang Z; Zou S; Ji H; Ge G; Du X; Hou A; Zhu Y; Cong Q; Xu J; Zu H; Wang Y; Yan Z; Yan X; BianBa Y; Ci Q; Zhang L; Yang S; Gao X; Zhong L; He S; Liu C; Huang Y; Liu Y; Xu D; Zhu Q; Xu X; Lv M; Zhang W; Qi X
Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1516-1524.e2. PubMed ID: 34942370
[TBL] [Abstract][Full Text] [Related]
12. Letter to the Editor: Breastfeeding and COVID-19 Vaccine: Yes We Can.
Mayo S; Monfort S
J Hum Lact; 2021 May; 37(2):275-276. PubMed ID: 33724882
[No Abstract] [Full Text] [Related]
13. Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases.
Thuluvath PJ; Robarts P; Chauhan M
J Hepatol; 2021 Dec; 75(6):1434-1439. PubMed ID: 34454993
[TBL] [Abstract][Full Text] [Related]
14. Letter to the Editor: Financial incentives for COVID-19 vaccination.
Kim HB
Epidemiol Health; 2021; 43():e2021088. PubMed ID: 34781635
[No Abstract] [Full Text] [Related]
15. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients.
Cornberg M; Buti M; Eberhardt CS; Grossi PA; Shouval D
J Hepatol; 2021 Apr; 74(4):944-951. PubMed ID: 33563499
[TBL] [Abstract][Full Text] [Related]
16. Clinical update on risks and efficacy of anti-SARS-CoV-2 vaccines in patients with autoimmune hepatitis and summary of reports on post-vaccination liver injury.
Lleo A; Cazzagon N; Rigamonti C; Cabibbo G; Lai Q; Muratori L; Carbone M;
Dig Liver Dis; 2022 Jun; 54(6):722-726. PubMed ID: 35410851
[TBL] [Abstract][Full Text] [Related]
17. Response to: myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related.
Quiñones-Moya H; Camargo-Coronel A; Hernández-Zavala MR
Reumatismo; 2023 Sep; 75(3):. PubMed ID: 37721344
[TBL] [Abstract][Full Text] [Related]
18. The vaccine-response in patients with cirrhosis after COVID-19 vaccination: A systematic analysis of 168,245 patients with cirrhosis.
Li Z; Hu Y; Zou B
J Hepatol; 2023 Oct; 79(4):e157-e162. PubMed ID: 37400016
[No Abstract] [Full Text] [Related]
19. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
20. Reply to letter to the editor "antibody responses to second doses of COVID-19 vaccination in lung cancer patients: Comment".
Narita D; Ebina-Shibuya R
Respir Investig; 2023 May; 61(3):347-348. PubMed ID: 36947984
[No Abstract] [Full Text] [Related]
[Next] [New Search]
